Accessibility Menu
Australis Capital logo

Australis Capital(OTC) AUSAF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year+0%
1 Month-90%
$0.00
+0.00%
+0.00Today
Australis Capital last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-11
Australis Capital stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-29
1 month-90%USD 0.002026-07-10
3 month+0%USD 0.002026-05-13
Year to date-99%USD 0.002025-12-31
1 year+0%USD 0.002025-08-11
3 year-99%USD 0.002023-08-11
5 year-100%USD 0.172021-08-12
Since inception-100%USD 1.992018-09-28

Australis Capital Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$6.37M

Net Income (TTM)

-CA$18.40M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-59022.42 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Sep 10, 2024

AUSAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Australis Capital

Australis Capital Inc. is a cannabis enterprise engaged in diverse cannabis and horticultural ventures across multiple international markets. The company operates in regions including the United States, Canada, and several European and Asian countries, positioning itself as a significant player in the global cannabis industry.

Products and Services
  • Development and management of cannabis cultivation facilities
  • Investment in cannabis-related businesses and technologies
  • Consulting services for cannabis market entry and compliance
Growth Outlook
  • Expansion into new international markets is underway
  • Increased demand for cannabis products is anticipated
  • Strategic partnerships are being formed to enhance market presence
Financial Highlights
  • Recent quarterly revenue of CAD 3,103,117 shows growth potential
  • Trailing twelve months (TTM) gross profit margin stands at 52.39%
  • Current ratio of 0.69 indicates liquidity management focus
The company is strategically positioned to capitalize on the growing global cannabis market. With a focus on expanding its operations internationally, Australis Capital Inc. aims to leverage increasing consumer demand for cannabis products. The recent quarterly revenue indicates a positive trend, suggesting that the company is on a path to recovery and growth. The gross profit margin reflects effective cost management, while the current ratio highlights a commitment to maintaining liquidity. Overall, Australis Capital Inc. presents an intriguing opportunity for investors interested in the evolving cannabis sector.
AI Generated • Jul 24, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Terry Booth

Website

ausa-corp.com

Headquarters

Las Vegas, NV 89119, US

AUSAF Financials

Key Financial Metrics (TTM)

Gross Margin

52.39%

Operating Margin

-255.97%

Net Income Margin

-661.50%

Return on Equity

-143.69%

Return on Capital

-82.85%

Return on Assets

-98.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

1

Avg. Volume

3.30K

Financials (TTM)

Gross Profit

CA$4.14M

Operating Income

-CA$12.15M

EBITDA

-CA$23.80M

Operating Cash Flow

-CA$8.80M

Capital Expenditure

-CA$134.89K

Free Cash Flow

-CA$8.94M

Cash & ST Invst.

CA$727.69

Total Debt

CA$0.00

Australis Capital Performance Analysis

Australis Capital annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-03-31CAD 7,556,203N/A
Australis Capital sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12021-06-30376230.4%
Q22021-09-3031.5%
Q32021-12-314.4%
Q42022-03-31-99.9%
Australis Capital annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-03-31CAD -0.16N/A
Australis Capital sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12021-06-30-335.8%
Q22021-09-3057.4%
Q32021-12-31-9.8%
Q42022-03-31-528.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2021YOY CHG

Revenue

CA$3.10K

+575.8%

Gross Profit

CA$1.73K

+7200.4%

Gross Margin

55.67%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

18

N/A

Net Income

-CA$31.72K

-101.0%

EBITDA

-CA$6.70M

-317.8%

Quarterly Fundamentals

Name
Q4 2021YOY CHG

Total Cash

CA$727.69

-82.6%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$3.55M

+112.7%

Inventory

CA$0.00

-100.0%

Long Term Debt

CA$2.45K

-99.8%

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-98.98%

N/A

Return on Invested Capital

-48.49%

N/A

Free Cash Flow

-CA$5.34K

-228.6%

Operating Cash Flow

-CA$5.37K

-309.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IONKFIonic Brands Corp.
$0.00+0.00%
CBIHCannabis Bioscience International Holdings, Inc.
$0.00+0.00%
LOBEFLobe Sciences Ltd.
$0.01-91.33%
TWSITristar Wellness Solutions Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About AUSAF

What is the current price of Australis Capital?

Australis Capital is trading at $0.00 per share.

What is the 52-week range for Australis Capital?

Over the past 52 weeks, Australis Capital has traded between $0.00 and $0.00.

How much debt does Australis Capital have?

Australis Capital total debt is unavailable.

How much cash does Australis Capital have on hand?

Australis Capital reported CA$582.60K in cash and cash equivalents in its most recent financial results.

What is Australis Capital’s dividend yield?

Australis Capital does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services